The Twenty Minute VCCost Plus Drugs: EXPLAINED | Mark Cuban Full Interview
Harry Stebbings and Mark Cuban on mark Cuban’s Cost Plus Drugs Attacks Soaring Prescription Prices Head-On.
In this episode of The Twenty Minute VC, featuring Harry Stebbings and Mark Cuban, Cost Plus Drugs: EXPLAINED | Mark Cuban Full Interview explores mark Cuban’s Cost Plus Drugs Attacks Soaring Prescription Prices Head-On Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. The business avoids insurance and pharmacy benefit managers (PBMs), instead selling directly to consumers at cost plus a 15% markup, a $3 handling fee, and $5 shipping. Cuban details the regulatory and supply-chain complexities of building a new kind of pharmacy and why having no outside investors lets him prioritize impact over profit. He also shares broader views on healthcare system misalignments, his philosophy on hiring, management, and goal setting, and personal perspectives on parenting, climate risk, and life priorities.
At a glance
WHAT IT’S REALLY ABOUT
Mark Cuban’s Cost Plus Drugs Attacks Soaring Prescription Prices Head-On
- Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. The business avoids insurance and pharmacy benefit managers (PBMs), instead selling directly to consumers at cost plus a 15% markup, a $3 handling fee, and $5 shipping. Cuban details the regulatory and supply-chain complexities of building a new kind of pharmacy and why having no outside investors lets him prioritize impact over profit. He also shares broader views on healthcare system misalignments, his philosophy on hiring, management, and goal setting, and personal perspectives on parenting, climate risk, and life priorities.
IDEAS WORTH REMEMBERING
7 ideasRadical price transparency can undercut traditional drug pricing structures.
By openly publishing a simple formula—drug cost plus 15%, $3 handling, $5 shipping—and bypassing insurance and PBMs, Cost Plus often beats both cash prices and insurance copays on generics.
Self-funding enables mission-first decisions over profit maximization.
Because Cuban has no outside investors, he can tolerate revenue volatility and resist pressure to add high-margin features or marketing, keeping focus on being the lowest-cost generic provider.
Success hinges on hiring exceptional operators and then delegating deeply.
Cuban emphasizes working with ‘rock star’ partners like Dr. Alex Oshmyansky, trusting them with operational complexity while he focuses on marketing, relationships, and strategic nuance.
Hire slow, fire fast—and distinguish stress removers from stress creators.
He advocates careful hiring, rapid exits for poor fits, and categorizing people by whether they reduce or manufacture stress; the former should be protected, the latter removed quickly.
Define goals around core customer value, not just revenue targets.
For Cost Plus, key metrics are repeat customers, number of drugs offered, and continuous price reductions; revenue and profit are secondary to building trust as the lowest-cost provider.
Organic, trust-based marketing can replace big ad budgets when value is clear.
Cuban wants new drug additions and ongoing price cuts themselves to be the marketing, counting on patient communities and word-of-mouth rather than large paid campaigns.
Healthcare’s misaligned incentives drive up prices and administrative waste.
He critiques how insurance medical loss ratios and hospital contracting reward higher gross spending, contributing to roughly 21% of US healthcare costs going to administration rather than care.
WORDS WORTH SAVING
5 quotesOur goal is to be the lowest cost provider of generic drugs, period, end of story.
— Mark Cuban
I’m financing it all myself… when you bring on investors, you’re gonna run it differently.
— Mark Cuban
I really divide people into stress creators and stress removers. The stress removers, you do everything you can to keep them.
— Mark Cuban
We’re not trying to optimize revenues, we’re not trying to optimize profits. We’re trying to optimize how many customers we have.
— Mark Cuban
Time is the most valuable asset you don’t own.
— Mark Cuban
QUESTIONS ANSWERED IN THIS EPISODE
5 questionsHow scalable is the Cost Plus model once you move beyond generics and into branded or specialty drugs?
Mark Cuban discusses Cost Plus Drugs, his self-funded company aiming to radically lower the price of generic medications through transparent, fixed-margin pricing. The business avoids insurance and pharmacy benefit managers (PBMs), instead selling directly to consumers at cost plus a 15% markup, a $3 handling fee, and $5 shipping. Cuban details the regulatory and supply-chain complexities of building a new kind of pharmacy and why having no outside investors lets him prioritize impact over profit. He also shares broader views on healthcare system misalignments, his philosophy on hiring, management, and goal setting, and personal perspectives on parenting, climate risk, and life priorities.
What specific regulatory or industry pushback does Cuban anticipate if Cost Plus reaches tens of millions of customers?
Could Cost Plus ever integrate with insurance in a way that preserves its transparency and low prices?
How might technologies like DAOs and decentralized validation realistically change insurance and claims processing in the next decade?
If 21% of US healthcare spending is administrative, what concrete structural reforms does Cuban believe are most politically feasible to reduce that overhead?
EVERY SPOKEN WORD
Install uListen for AI-powered chat & search across the full episode — Get Full Transcript
Get more out of YouTube videos.
High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.
Add to Chrome